# ğŸ“… Daily Report - 2026-02-20

> ä»Šæ—¥ç­›é€‰å‡º **115** æ¡å†…å®¹ï¼Œæ¥è‡ª **2** ä¸ªæ¥æº

<div class="powered-by-top">Powered by <a href="https://kyplus.de">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai">Claude</a></div>

---

## ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“

### ğŸ§¬ æ•°æ®å‰æ²¿

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
ç©ºé—´è½¬å½•ç»„å­¦åœ¨è‚¿ç˜¤ç»†èƒå‘½è¿å†³å®šï¼ˆç¥ç»æ¯ç»†èƒç˜¤æ·‹å·´ç»“è½¬ç§»ï¼‰åŠè‚ é“æŸä¼¤æœºåˆ¶è§£æä¸­å–å¾—çªç ´ï¼Œæ­ç¤ºäº†ç»†èƒå¼‚è´¨æ€§ã€åˆ†åŒ–åŠé€šè®¯æœºåˆ¶ã€‚

**ä¸»è¦æ–¹å‘**ï¼š
- è‚¿ç˜¤å¾®ç¯å¢ƒè°ƒæ§ä¸å…ç–«æ²»ç–—ï¼šç ”ç©¶ALOX15Båœ¨å¼¥æ¼«å¤§Bç»†èƒæ·‹å·´ç˜¤ä¸­çš„å…ç–«æŠ‘åˆ¶ä½œç”¨ï¼Œä»¥åŠMETTL5åœ¨å¢å¼ºè‚¿ç˜¤å…ç–«ååº”ä¸­çš„ä½œç”¨ã€‚
- ç™Œç—‡å‘ç”Ÿä¸è¿›å±•æœºåˆ¶ï¼šæ¢ç´¢ç¥ç»æ¯ç»†èƒç˜¤è½¬ç§»çš„è½¬å½•è°ƒæ§ï¼Œä»¥åŠCOL1A2åœ¨ä¹³è…ºç™Œè€è¯æ€§ä¸­çš„é¢„æµ‹ä½œç”¨ã€‚
- è‚ é“å¥åº·ä¸ç–¾ç—…ï¼šåˆ©ç”¨å•æ ¸/ç©ºé—´è½¬å½•ç»„å­¦è§£æSAPè¯±å¯¼çš„è‚ é“æŸä¼¤æœºåˆ¶ï¼Œä»¥åŠæ¯ä½“è‚ é“èŒç¾¤å¯¹åä»£è‚ é“å¥åº·çš„å½±å“ã€‚

**æŠ€æœ¯äº®ç‚¹**ï¼š
- ç©ºé—´è½¬å½•ç»„å­¦ä¸å•æ ¸è½¬å½•ç»„å­¦ï¼šç»“åˆå¤šç»„å­¦æŠ€æœ¯ï¼Œå®ç°å¯¹è‚¿ç˜¤ã€è‚ é“ç­‰å¤æ‚ç»„ç»‡ä¸­ç»†èƒå¼‚è´¨æ€§ã€ç©ºé—´åˆ†å¸ƒåŠåŠŸèƒ½çŠ¶æ€çš„ç²¾ç»†è§£æã€‚

### ğŸ§ª åšå®¢æ›´æ–°

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
ä¸€é¡¹çªç ´æ€§ç ”ç©¶å‘ç°ï¼Œå¸¦çŠ¶ç–±ç–¹ç–«è‹—åœ¨å¯¹æŠ—é˜¿å°”èŒ¨æµ·é»˜ç—…æ–¹é¢å±•ç°å‡ºæƒŠäººæ½œåŠ›ã€‚

**ä¸»è¦æ–¹å‘**ï¼š
- åˆ©ç”¨ç°æœ‰è¯ç‰©ï¼ˆå¦‚è¥¿åœ°é‚£éã€å¸¦çŠ¶ç–±ç–¹ç–«è‹—ï¼‰å¼€å‘é˜¿å°”èŒ¨æµ·é»˜ç—…æ–°ç–—æ³•ã€‚
- ç ”å‘æ–°å‹HPVç–«è‹—ï¼Œé€šè¿‡é‡æ’HPVè›‹ç™½ç‰‡æ®µè®­ç»ƒTç»†èƒé¶å‘ç™Œç»†èƒã€‚

**æŠ€æœ¯äº®ç‚¹**ï¼š
- æ¢ç´¢DNAçº³ç±³ç»“æ„åœ¨é‡æ’æŠ—åŸç‰‡æ®µä¸­çš„åº”ç”¨ï¼Œæå‡ç™Œç—‡ç–«è‹—æ•ˆèƒ½ã€‚
- å¯¹æ¯”åˆ†ææ¶²æ»´ä¸çš®å‡çº§å•ç»†èƒè½¬å½•ç»„æµ‹åºå¹³å°åœ¨ä¿å­˜ç»†èƒç±»å‹å’Œæ•°æ®è´¨é‡æ–¹é¢çš„å·®å¼‚ã€‚

---

## ğŸ“š åˆ†ç±»æµè§ˆ

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (112æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰

**1.** â­ **GSE309269 ç¥ç»æ¯ç»†èƒç˜¤æ·‹å·´ç»“è½¬ç§»ä¸­å†³å®šè‚¿ç˜¤ç»†èƒå‘½è¿çš„è½¬å½•ç¨‹åº[ç©ºé—´è½¬å½•ç»„å­¦]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼štumorã€lymphã€regex:lymph(o|atic)?ã€spatialã€spatial transcriptomicsã€transcriptomics
- ğŸ“ **æè¿°**ï¼šContributors : Natalie Wu ; Richard LuSeries Type : OtherOrganism : Homo sapiensNeuroblastoma, a deadly pediatric cancer from the sympathetic ganglia of the peripheral nervous system, frequently metastasizes, driving poor outcomes in high-risk cases. While primary tumors are well-characterized, the cellular and molecular dynamics of metastasis remain poorly understood. Here, we employed single-cell multi-omics and spatial transcriptomics to profile lymph node metastases in high-risk neuroblastoma compared to primary adrenal masses. We found that lymph node metastases displayed unique cellular heterogeneity and plasticity marked by a shift toward mesenchymal-like and cancer stem cell states, with enriched epithelial-to-mesenchymal transition (EMT) programs. Lymph node metastatic niche exhibited altered tumor microenvironment dynamics, characterized by increased immunosuppressive myeloid subsets, heightened immune checkpoint signaling and lymphocyte exhaustion, indicative of immune evasion and dysfunction. Our multi-omics studies reveal distinct features of high-risk neuroblastoma that contribute to metastasis and therapy resistance, pointing to potential therapeutic vulnerabilities of the aggressive metastatic disease.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309269)

**2.** â­ **GSE294509 ALOX15B ä½è¡¨è¾¾é€šè¿‡ TAP1/MHC-I è½´è°ƒèŠ‚å¼¥æ¼«æ€§å¤§ B ç»†èƒæ·‹å·´ç˜¤ä¸­çš„å…ç–«æŠ‘åˆ¶æ€§è‚¿ç˜¤å¾®ç¯å¢ƒ**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼štumorã€lymphomaã€tumor microenvironmentã€B cellã€MHC
- ğŸ“ **æè¿°**ï¼šContributors : Lanxin Zhang ; Yucui ShangSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe arachidonic acid (AA) metabolism is closely related to tumor immune evasion and chemo-resistance. ALOX15B (arachidonate 15-lipoxygenase type B), located on chromosome 17p, encodes a key enzyme in AA pathway. Interestingly, the expression of ALOX15B is independent of 17p status but is epigenetically regulated. Low ALOX15B expression predicts poor prognosis, with PGE2 activation and TAP1 suppression, reducing MHC-I expression and creating an immunosuppressive microenvironment. Tucidinostat, a histone deacetylase (HDAC) inhibitor, restores ALOX15B and enhances the TAP1/MHC-I axis, thus promoting lymphoma cell apoptosis, which correlates with the effect of tucidinostat plus immunochemotherapy in a phase II trial of patients with newly diagnosed DLBCL (NCT02753647). Our study provides insight into a novel therapeutic strategy to improve patient prognosis by epigenetically modulating lymphoma metabolism and optimizing the tumor microenvironment.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294509)

**3.** â­ **GSE317063 å•æ ¸å’Œç©ºé—´è½¬å½•ç»„å­¦æ­ç¤º SAP è¯±å¯¼çš„è‚ é“æŸä¼¤ä¸­è‚ é“ç»†èƒå¼‚è´¨æ€§ã€åˆ†åŒ–å’Œç»†èƒé€šè®¯æœºåˆ¶**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šspatialã€spatial transcriptomicsã€transcriptomicsã€regex:intestin(e|al)
- ğŸ“ **æè¿°**ï¼šSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Rattus norvegicusThis SuperSeries is composed of the SubSeries listed below.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317063)

**4.** â­ **GSE317062 å•æ ¸å’Œç©ºé—´è½¬å½•ç»„å­¦æ­ç¤º SAP è¯±å¯¼çš„è‚ é“æŸä¼¤ä¸­è‚ é“ç»†èƒå¼‚è´¨æ€§ã€åˆ†åŒ–å’Œç»†èƒé€šè®¯æœºåˆ¶ [ç©ºé—´è½¬å½•ç»„å­¦]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šspatialã€spatial transcriptomicsã€transcriptomicsã€regex:intestin(e|al)
- ğŸ“ **æè¿°**ï¼šContributors : Lechang Zhang ; Changqin Xu ; Tong Su ; Tong Xiao ; Xu Yi ; Yuemin Feng ; Jing Wang ; Shulei ZhaoSeries Type : OtherOrganism : Rattus norvegicusBackground Acute pancreatitis (AP) is a severe inflammatory disease that frequently causes multi-organ damage, with intestinal injury being a major complication. The mechanisms underlying SAP-induced intestinal injury remain unclear, particularly regarding spatial cellular reorganization and functional interactions. Methods This study constructed a severe acute pancreatitis (SAP) rat model and employed single-nucleus RNA sequencing (snRNA-seq) and spatial transcriptome sequencing (stRNA-seq) technologies to systematically analyze the dynamic changes in intestinal cellular composition, spatial distribution, and function during SAP-induced intestinal injury. Results snRNA-seq identified 18 major ileal cell populations spanning epithelial, immune, stem/TA, and stromal compartments. SAP was associated with compositional remodeling characterized by downward trends in Lgr5âº/Olfm4âº stem cells, TA1, goblet cells, and Paneth cells, with a reciprocal increase in enterocytes, although most proportion changes did not reach statistical significance at the animal level. Spatial transcriptomics independently captured SAP-associated tissue remodeling, including a significant reduction in Paneth cells accompanied by increases in fat cells, macrophages, goblet cells, and TA2 cells. Across epithelial lineages, SAP induced a transcriptional shift toward immune interaction with up-regulation of antigen presentationâ€“related genes (e.g., Cd74, Apoa1) and down-regulation of antimicrobial/barrier effectors (e.g., Defa24, Pla2g2a, Dmbt1), which was corroborated by spatial expression patterns and spatially variable gene programs enriched for host defense responses. Pseudotime analysis suggested a redistribution of epithelial states along the stem/TA-to-enterocyte continuum, with relative depletion of early states and expansion of enterocyte-dominant states in SAP. CellChat analysis revealed globally intensified intercellular communication and nominated FN1 as the pathway with the highest differential information flow, with Lgr5âº stem cells predicted as prominent FN1 senders targeting enterocytes and smooth muscle cells. SCENIC identified reduced activity and expression of Hmga2/Myb regulons in stem compartments, and immunofluorescence showed decreasing trends in Hmga2/Myb-positive Olfm4âº and Lgr5âº stem cells in SAP. Conclusion...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317062)

**5.** â­ **GSE317060 å•æ ¸å’Œç©ºé—´è½¬å½•ç»„å­¦æ­ç¤º SAP è¯±å¯¼çš„è‚ é“æŸä¼¤ä¸­è‚ é“ç»†èƒå¼‚è´¨æ€§ã€åˆ†åŒ–å’Œç»†èƒé€šè®¯æœºåˆ¶ [snRNA-seq]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šspatialã€spatial transcriptomicsã€transcriptomicsã€regex:intestin(e|al)
- ğŸ“ **æè¿°**ï¼šContributors : Lechang Zhang ; Changqin Xu ; Tong Su ; Tong Xiao ; Xu Yi ; Yuemin Feng ; Jing Wang ; Shulei ZhaoSeries Type : Expression profiling by high throughput sequencingOrganism : Rattus norvegicusBackground Acute pancreatitis (AP) is a severe inflammatory disease that frequently causes multi-organ damage, with intestinal injury being a major complication. The mechanisms underlying SAP-induced intestinal injury remain unclear, particularly regarding spatial cellular reorganization and functional interactions. Methods This study constructed a severe acute pancreatitis (SAP) rat model and employed single-nucleus RNA sequencing (snRNA-seq) and spatial transcriptome sequencing (stRNA-seq) technologies to systematically analyze the dynamic changes in intestinal cellular composition, spatial distribution, and function during SAP-induced intestinal injury. Results snRNA-seq identified 18 major ileal cell populations spanning epithelial, immune, stem/TA, and stromal compartments. SAP was associated with compositional remodeling characterized by downward trends in Lgr5âº/Olfm4âº stem cells, TA1, goblet cells, and Paneth cells, with a reciprocal increase in enterocytes, although most proportion changes did not reach statistical significance at the animal level. Spatial transcriptomics independently captured SAP-associated tissue remodeling, including a significant reduction in Paneth cells accompanied by increases in fat cells, macrophages, goblet cells, and TA2 cells. Across epithelial lineages, SAP induced a transcriptional shift toward immune interaction with up-regulation of antigen presentationâ€“related genes (e.g., Cd74, Apoa1) and down-regulation of antimicrobial/barrier effectors (e.g., Defa24, Pla2g2a, Dmbt1), which was corroborated by spatial expression patterns and spatially variable gene programs enriched for host defense responses. Pseudotime analysis suggested a redistribution of epithelial states along the stem/TA-to-enterocyte continuum, with relative depletion of early states and expansion of enterocyte-dominant states in SAP. CellChat analysis revealed globally intensified intercellular communication and nominated FN1 as the pathway with the highest differential information flow, with Lgr5âº stem cells predicted as prominent FN1 senders targeting enterocytes and smooth muscle cells. SCENIC identified reduced activity and expression of Hmga2/Myb regulons in stem compartments, and immunofluorescence showed decreasing trends in Hmga2/Myb-positive O...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317060)

**6.** â­ **GSE309268 ç¥ç»æ¯ç»†èƒç˜¤æ·‹å·´ç»“è½¬ç§»ä¸­å†³å®šè‚¿ç˜¤ç»†èƒå‘½è¿çš„è½¬å½•ç¨‹åº[å•ç»†èƒå¤šç»„å­¦]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼štumorã€lymphã€regex:lymph(o|atic)?ã€single-cell
- ğŸ“ **æè¿°**ï¼šContributors : Natalie Wu ; Brian Weiss ; Richard LuSeries Type : Genome binding/occupancy profiling by high throughput sequencing ; Expression profiling by high throughput sequencingOrganism : Homo sapiensNeuroblastoma, a deadly pediatric cancer from the sympathetic ganglia of the peripheral nervous system, frequently metastasizes, driving poor outcomes in high-risk cases. While primary tumors are well-characterized, the cellular and molecular dynamics of metastasis remain poorly understood. Here, we employed single-cell multi-omics and spatial transcriptomics to profile lymph node metastases in high-risk neuroblastoma compared to primary adrenal masses. We found that lymph node metastases displayed unique cellular heterogeneity and plasticity marked by a shift toward mesenchymal-like and cancer stem cell states, with enriched epithelial-to-mesenchymal transition (EMT) programs. Lymph node metastatic niche exhibited altered tumor microenvironment dynamics, characterized by increased immunosuppressive myeloid subsets, heightened immune checkpoint signaling and lymphocyte exhaustion, indicative of immune evasion and dysfunction. Our multi-omics studies reveal distinct features of high-risk neuroblastoma that contribute to metastasis and therapy resistance, pointing to potential therapeutic vulnerabilities of the aggressive metastatic disease.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309268)

**7.** â­ **GSE309267 ç¥ç»æ¯ç»†èƒç˜¤æ·‹å·´ç»“è½¬ç§»ä¸­å†³å®šè‚¿ç˜¤ç»†èƒå‘½è¿çš„è½¬å½•ç¨‹åº [æ‰¹é‡ RNA æµ‹åº]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼štumorã€lymphã€regex:lymph(o|atic)?ã€RNA-seq
- ğŸ“ **æè¿°**ï¼šContributors : Natalie Wu ; Brian Weiss ; Richard LuSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensNeuroblastoma, a deadly pediatric cancer from the sympathetic ganglia of the peripheral nervous system, frequently metastasizes, driving poor outcomes in high-risk cases. While primary tumors are well-characterized, the cellular and molecular dynamics of metastasis remain poorly understood. Here, we employed single-cell multi-omics and spatial transcriptomics to profile lymph node metastases in high-risk neuroblastoma compared to primary adrenal masses. We found that lymph node metastases displayed unique cellular heterogeneity and plasticity marked by a shift toward mesenchymal-like and cancer stem cell states, with enriched epithelial-to-mesenchymal transition (EMT) programs. Lymph node metastatic niche exhibited altered tumor microenvironment dynamics, characterized by increased immunosuppressive myeloid subsets, heightened immune checkpoint signaling and lymphocyte exhaustion, indicative of immune evasion and dysfunction. Our multi-omics studies reveal distinct features of high-risk neuroblastoma that contribute to metastasis and therapy resistance, pointing to potential therapeutic vulnerabilities of the aggressive metastatic disease.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309267)

**8.** â­ **GSE298759 æ¯ä½“è‚ é“å¾®ç”Ÿç‰©é—ä¼ å½±å“åä»£è‚ é“å¥åº·å’Œç»“è‚ ç‚æ˜“æ„Ÿæ€§**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šregex:micro(b|be|bial|organism)ã€gutã€regex:gut(-?microbiome)?ã€regex:intestin(e|al)
- ğŸ“ **æè¿°**ï¼šContributors : Ji-Min Lee ; Hoyul Lee ; Eun Soo KimSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusOffspring born to mothers with colitis exhibited gut microbial dysbiosis, impaired barrier function, low-grade intestinal inflammation, compromised Wnt signaling and reduced crypt cell proliferation, which collectively increased their susceptibility to colitis in adulthood.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298759)

**9.** â­ **GSE299589 å…‹éš†åŠ¨åŠ›å­¦æ­ç¤ºç™Œç—‡è€è¯æ€§æºäºé€‚åº”æ€§ç¨‹åº [RNA-Seq]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€resistanceã€RNA-seq
- ğŸ“ **æè¿°**ï¼šContributors : Haiyin Li ; Yeqing Chen ; Jessica Kaster ; Maggie Dunne ; Min Xiao ; Ling Li ; Monzy Thomas ; Nazifa Promi ; Dylan Fingerman ; Gregory S Brown ; Xingyue Zhu ; Meenhard HerlynSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensMost advanced cancers initially respond to targeted therapies but eventually relapse1. Rather than acquiring new mutations, resistance is driven by drug-tolerant persister cells (DTP) that enter a reversible drug-refractory state and sustain minimal residual disease2. Here, we developed MeRLin, a high-resolution barcoding platform combining single-cell RNA sequencing, RNA fluorescence in situ hybridization, and computational analyses to track clonal and transcriptional dynamics of melanoma cells during targeted therapy. Clonal tracking reveals that dominant resistant clones arise from minor pre-treatment subpopulations. The pre-treatment melanoma populations diversify into phenotypically distinct DTP subpopulations, marked by stress-like, lipid metabolism, PI3K signaling, and extracellular matrix remodeling programs associated with adaptive resistance. Spatial transcriptomics revealed the co-localization of lipid metabolism and PI3K signaling programs near the tumor boundaries, and a complex network of autocrine and paracrine interactions among DTP subpopulations. Using barcoded RNA fluorescence in situ hybridization, we identified a dominant persister subpopulation in resistant tumors marked by SLC2A1 expression. Thus, MeRLin provides a robust framework to dissect melanoma heterogeneity and uncover vulnerabilities in persister populations to improve long-term treatment efficacy.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299589)

**10.** â­ **GSE294261 é˜¿å°”èŒ¨æµ·é»˜ç—…å°é¼ æ¨¡å‹çš„å¤šç»„å­¦å•æ ¸åˆ†æè¡¨æ˜ ACSS2 èµ‹äºˆç¥ç»å…ƒæŠµæŠ— tau è›‹ç™½ç—…å˜çš„èƒ½åŠ› [RNA-Seq]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šAlzheimerã€Neuronalã€RNA-seq
- ğŸ“ **æè¿°**ï¼šContributors : Gabor Egervari ; Desi Alexander ; Hua Huang ; Greg Donahue ; Connor Hogan ; Mariel Mendoza ; Hong Xu ; Virginia Lee ; Ben A Garcia ; Nancy M Bonini ; Shelley L BergerSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusLoss of cell identity and global epigenomic dysregulation are emerging as key contributors to Alzheimerâ€™s disease (AD). The mechanisms by which protective or risk-conferring epigenetic marks are established and maintained are under intense investigation. ACSS2 (Acetyl-CoA Synthetase 2) is a key metabolic enzyme that is nuclear-localized in neurons. In healthy brains, ACSS2 fuels histone acetylation and drives expression of neuronal genes that regulate learning and memory. Here, we examine how loss of ACSS2 contributes to AD-associated cellular, genomic and behavioral outcomes, focusing on long-term steady state changes. Using a mouse model of human pathological AD-Tau injection, we show that loss of ACSS2 exacerbates Tau-related memory impairments, while dietary supplementation of acetate rescues learning in an ACSS2-dependent manner. Combining state-of-the-art proteomic and genomic approaches, we demonstrate that this effect is accompanied by ACSS2-dependent incorporation of acetate into hippocampal histone acetylation, which facilitates gene expression programs related to learning. We identify the most severely affected hippocampal neuronal populations, including pyramidal cells of the perforant pathway and Cajal-Retzius cells. Overall, these results reveal ACSS2 as a neuroprotective metabolic enzyme in key hippocampal neuronal populations, and dysregulation of which may play an important role in the etiology of AD. These findings may guide development of future therapies for AD, other tauopathies and related dementia.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294261)

> ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 102 æ¡å†…å®¹ï¼Œè¯¦è§ [æ–‡æœ«](#æ›´å¤š-æ•°æ®å‰æ²¿)

</div>

</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰

**1.** **ä¼Ÿå“¥å’Œå¸¦çŠ¶ç–±ç–¹ç–«è‹—åœ¨å¯¹æŠ—é˜¿å°”èŒ¨æµ·é»˜ç—…æ–¹é¢å±•ç°å‡ºä»¤äººæƒŠè®¶çš„æ½œåŠ›ã€‚**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼švaccineã€Alzheimer
- ğŸ“ **æè¿°**ï¼šA major new study has spotlighted three familiar medicines that could take on an unexpected new role in the fight against Alzheimerâ€™s disease â€” with a shingles vaccine emerging as the front-runner. After reviewing 80 existing drugs, an international panel of experts identified Zostavax, Viagra (sildenafil), and riluzole as the most promising candidates for repurposing.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.sciencedaily.com/releases/2026/02/260217005759.htm)

**2.** **è¿™ç§ç»è¿‡é‡æ–°è®¾è®¡çš„HPVç–«è‹—å¯ä»¥è®­ç»ƒTç»†èƒæ¥å¯¹æŠ—ç™Œç»†èƒã€‚**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€vaccine
- ğŸ“ **æè¿°**ï¼šNorthwestern researchers have shown that when it comes to cancer vaccines, arrangement can be just as important as ingredients. By repositioning a small fragment of an HPV protein on a DNA-based nanovaccine, the team dramatically strengthened the immune systemâ€™s attack on HPV-driven tumors. One specific design slowed tumor growth, extended survival in animal models, and unleashed far more cancer-killing T cells than other versions made with the exact same components.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.sciencedaily.com/releases/2026/02/260216044006.htm)

**3.** **æ¶²æ»´ä¸çš®å­”â€”â€”å•ç»†èƒè½¬å½•ç»„åˆ†æçš„è€ƒé‡å› ç´ **
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šsingle-cell
- ğŸ“ **æè¿°**ï¼šA head to head comparison of single cell RNA sequencing platforms reveals how droplet and picowell methods differ in preserving epithelial cells and data quality in human colon biopsies
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.rna-seqblog.com/droplet-vs-picowell-considerations-for-single-cell-transcriptomic-profiling/)


</div>

</details>

## ğŸ“Š å…³é”®è¯ç»Ÿè®¡

| å…³é”®è¯ | å‡ºç°æ¬¡æ•° |
|--------|----------|
| cancer | 19 |
| tumor | 18 |
| RNA-seq | 15 |
| immune | 11 |
| single-cell | 9 |
| spatial | 7 |
| transcriptomics | 7 |
| transcriptome | 7 |
| spatial transcriptomics | 6 |
| sequencing | 6 |
| epigenetic | 6 |
| T cell | 5 |
| pathway | 5 |
| regex:intestin(e|al) | 5 |
| macrophage | 5 |
| carcinoma | 4 |
| metabolism | 4 |
| methylation | 4 |
| resistance | 3 |
| metabolic | 3 |

---

## ğŸ“ æ›´å¤šå†…å®¹

<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (102æ¡)</summary>

<div class="details-content" markdown="1">

- [GSE274051ï¼šHIVç›¸å…³ééœå¥‡é‡‘æ·‹å·´ç˜¤çš„ç©ºé—´è½¬å½•ç»„å­¦åˆ†æï¼ˆæŒ‰EBVçŠ¶æ€å’Œèµ·æºç»†èƒåˆ†ç±»ï¼‰](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274051)
- [GSE319949 åˆ©ç”¨ç©ºé—´è½¬å½•ç»„å­¦è¿›è¡Œé€»è¾‘å›å½’ä»¥ä¼°è®¡åŠŸèƒ½æ•ˆåº”](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319949)
- [GSE287688 æ€§åˆ«ç‰¹å¼‚æ€§ KDM6A-HNF4A-CREBH ç½‘ç»œé€šè¿‡è‚ç»†èƒçš„è¡¨è§‚é—ä¼ é‡ç¼–ç¨‹æ§åˆ¶è„‚è›‹ç™½èƒ†å›ºé†‡ä»£è°¢å’ŒåŠ¨è„‰ç²¥æ ·ç¡¬åŒ– [RNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287688)
- [GSE319840 æ‚£è€…æ¥æºç»†èƒç³»æ­ç¤º COL1A2 å¯ä½œä¸ºä¹³è…ºç™Œå¤šè¥¿ä»–èµ›è€è¯æ€§çš„é¢„æµ‹å› å­](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319840)
- [GSE316985 CRISPRç­›é€‰å‘ç°PRMT7æ˜¯å¢å¼ºä¹³è…ºç™Œä¸­Tç»†èƒä»‹å¯¼æ€ä¼¤ä½œç”¨çš„æ²»ç–—é¶ç‚¹](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316985)
- [GSE311274 åŠ¨åŠ›è›‹ç™½1é€šè¿‡æ¿€æ´»PI3K/Aktä¿¡å·é€šè·¯ä¿ƒè¿›ç»“ç›´è‚ ç™Œè¿›å±•](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311274)
- [GSE310656 æä»æ ¸ä¸­çš„ç¤¾ä¼šåŠ å·¥ï¼šå•æ ¸RNAæµ‹åºæ­ç¤ºäº†å¯¹ä¼˜åŠ¿çº¿ç´¢å’ŒåŠ£åŠ¿çº¿ç´¢çš„ä¸åŒç¥ç»å…ƒååº”](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310656)
- [GSE308582 å•æ ¸ç»†èƒåœ¨é‡åˆ°æ‚£è€…æ¥æºçš„ç»“è‚ ç™Œç±»å™¨å®˜åè·å¾—è‚¿ç˜¤ç›¸å…³çš„IL1Bç¨‹åº](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308582)
- [GSE306674 å¤ªå¹³æ´‹ç™½è™¾è‚èƒ°è…ºæ„ŸæŸ“å‰¯æº¶è¡€å¼§èŒçš„å•ç»†èƒRNAæµ‹åº](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306674)
- [GSE305993 è‚¾ç»†èƒç™Œç»„ç»‡è½¬å½•ç»„åˆ†æ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305993)
- [GSE304262 è‚¾ç»†èƒç™Œä¸­è‚¿ç˜¤æµ¸æ¶¦æ·‹å·´ç»†èƒçš„å•ç»†èƒè½¬å½•ç»„åˆ†æï¼Œç”¨äºåŸºå› è¡¨è¾¾å’ŒTç»†èƒå—ä½“å…ç–«è°±åˆ†æ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304262)
- [GSE301394 ç ”ç©¶å‘ç°ï¼Œè¾›ä¼ä»–æ±€é€šè¿‡é’™-NFATC3é€šè·¯æŠ‘åˆ¶CD4+Tç»†èƒæ´»åŒ–ï¼Œä»è€Œç¼“è§£ConAè¯±å¯¼çš„è‡ªèº«å…ç–«æ€§è‚ç‚ã€‚](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301394)
- [GSE299761 METTL5é˜»æ–­é€šè¿‡è¯±å¯¼æ–°æŠ—åŸç”Ÿæˆå¢å¼ºæŠ—è‚¿ç˜¤å…ç–«ååº”](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299761)
- [GSE298789 å¤šåŠŸèƒ½å¤–æ³Œä½“æŠ‘åˆ¶è‡ªå™¬å¯æ”¹å–„éå°ç»†èƒè‚ºç™Œçš„å…ç–«è€å— II](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298789)
- [GSE298562 å¤šåŠŸèƒ½å¤–æ³Œä½“æŠ‘åˆ¶è‡ªå™¬å¯æ”¹å–„éå°ç»†èƒè‚ºç™Œçš„å…ç–«è€å—æ€§](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298562)
- [GSE283984 é€šè¿‡å¤šç»„å­¦ç»†èƒè½¬å½•ç»„å’Œè¡¨ä½æµ‹åºï¼ˆCITE-seqï¼‰åˆ†ææ­ç¤ºäººç±»å¤–å‘¨è¡€ B ç»†èƒåŒºå®¤å¤æ‚æ€§çš„æµç¨‹](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283984)
- [GSE280614 åˆ©ç”¨ CRISPR æ¡å½¢ç ä½œä¸ºåˆ†å­é’Ÿä»¥å•ç»†èƒåˆ†è¾¨ç‡æ•è·åŠ¨æ€è¿‡ç¨‹ [scRNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280614)
- [GSE280613 åˆ©ç”¨ CRISPR æ¡å½¢ç ä½œä¸ºåˆ†å­é’Ÿæ•è·å•ç»†èƒåˆ†è¾¨ç‡çš„åŠ¨æ€è¿‡ç¨‹ [RNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280613)
- [GSE278771 CD44v6 ä¸è†€èƒ±ç™Œçš„è‚¿ç˜¤ä¾µè¢­æ€§å’ŒåŒ–ç–—è€è¯æ€§ç›¸å…³](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE278771)
- [GSE276685 CD44v6 ä¸è†€èƒ±ç™Œçš„è‚¿ç˜¤ä¾µè¢­æ€§å’ŒåŒ–ç–—è€è¯æ€§ç›¸å…³](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE276685)
- [GSE276545 CD44v6 ä¸è†€èƒ±ç™Œçš„è‚¿ç˜¤ä¾µè¢­æ€§å’ŒåŒ–ç–—è€è¯æ€§ç›¸å…³](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE276545)
- [GSE247166 çº¿ç²’ä½“åº”æ¿€å¯¹è‚ é“è‚¿ç˜¤å‘å±•çš„å½±å“å–å†³äºApcçŠ¶æ€](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE247166)
- [GSE319930 Delta-8-å››æ°¢å¤§éº»é…šé€šè¿‡è¡¨è§‚é—ä¼ è°ƒæ§å…ç–«åŠ¨åŠ›å­¦å‡è½»å°é¼ è‡ªèº«å…ç–«æ€§è‚ç‚](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319930)
- [GSE319924 Netrin-1é˜»æ–­å¯ç¼“è§£å±€éƒ¨æ™šæœŸèƒ°è…ºç™Œå¯¹ä¸€çº¿åŒ–ç–—çš„è€è¯æ€§](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319924)
- [GSE304367 æŠ—ä½“ CR3022 çš„ä½“å†…è¿›åŒ–æ‰©å¤§äº†å¯¹ SARS-CoV-2 å˜ç§çš„äº¤å‰ä¸­å’Œä½œç”¨ï¼Œå¹¶ä¸ºæ³›æ²™è´ç—…æ¯’å…ç–«æä¾›äº†ä¿¡æ¯](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304367)
- [GSE294631 éæ´²çˆªèŸ¾å˜æ€å‘è‚²è¿‡ç¨‹ä¸­è„Šé«“çš„å•ç»†èƒRNAæµ‹åº](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294631)
- [GSE255827 åŸºå› ç»„å¼‚è´¨æ€§é©±åŠ¨äººç±»è‚¿ç˜¤ç»†èƒçš„æœºæ¢°é€‚åº” [ATAC-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255827)
- [GSE215962 é€šè¿‡å•ç»†èƒè¡¨è¾¾çªå˜è°±æ­ç¤ºçš„äºšå…‹éš†è¿›åŒ–ï¼Œæ­ç¤ºäº†é»‘è‰²ç´ ç˜¤å¯¹å…ç–«ç–—æ³•çš„é€‚åº”æœºåˆ¶ [bWTS]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE215962)
- [GSE215961 é€šè¿‡å•ç»†èƒè¡¨è¾¾çªå˜è°±æ­ç¤ºçš„äºšå…‹éš†è¿›åŒ–ï¼Œæ­ç¤ºäº†é»‘è‰²ç´ ç˜¤å¯¹å…ç–«ç–—æ³•çš„é€‚åº”æœºåˆ¶ [bWES]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE215961)
- [GSE215959 é€šè¿‡å•ç»†èƒè¡¨è¾¾çªå˜è°±æ­ç¤ºçš„äºšå…‹éš†è¿›åŒ–ï¼Œæ­ç¤ºäº†é»‘è‰²ç´ ç˜¤å¯¹å…ç–«ç–—æ³•çš„é€‚åº”æœºåˆ¶ [M4_aCTLA4_scRNA]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE215959)
- [GSE319589 DNAç”²åŸºåŒ–æ¨¡å¼æ­ç¤ºäº†ç‚ç—‡è‡´æ•ç¼ºæ°§ç¼ºè¡€æ€§è„‘ç—…ä¸­ç¥ç»ç³»ç»Ÿé£é™©çš„ç»†èƒæœºåˆ¶](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319589)
- [GSE315460 å·¨å™¬ç»†èƒ-ç¥ç»èƒ¶è´¨ç»†èƒç›¸äº’ä½œç”¨è°ƒèŠ‚è¥¿å°¼ç½—æ²³ç—…æ¯’æ„ŸæŸ“æœŸé—´å¯¹è‚ ç¥ç»å…ƒçš„å…ç–«æŸä¼¤[4]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315460)
- [GSE315459 å·¨å™¬ç»†èƒ-ç¥ç»èƒ¶è´¨ç»†èƒç›¸äº’ä½œç”¨è°ƒèŠ‚è¥¿å°¼ç½—æ²³ç—…æ¯’æ„ŸæŸ“æœŸé—´å¯¹è‚ ç¥ç»å…ƒçš„å…ç–«æŸä¼¤[3]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315459)
- [GSE315457 å·¨å™¬ç»†èƒ-ç¥ç»èƒ¶è´¨ç»†èƒç›¸äº’ä½œç”¨è°ƒèŠ‚è¥¿å°¼ç½—æ²³ç—…æ¯’æ„ŸæŸ“æœŸé—´å¯¹è‚ ç¥ç»å…ƒçš„å…ç–«æŸä¼¤[2]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315457)
- [GSE315454 å·¨å™¬ç»†èƒ-ç¥ç»èƒ¶è´¨ç»†èƒç›¸äº’ä½œç”¨è°ƒèŠ‚è¥¿å°¼ç½—æ²³ç—…æ¯’æ„ŸæŸ“æœŸé—´å¯¹è‚ ç¥ç»å…ƒçš„å…ç–«æŸä¼¤[1]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315454)
- [GSE308548 å•æ ¸ç»†èƒåœ¨é‡åˆ°æ‚£è€…æ¥æºçš„ç»“è‚ ç™Œç±»å™¨å®˜åè·å¾—è‚¿ç˜¤ç›¸å…³çš„IL1Bç¨‹åº](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308548)
- [GSE296864 è…¹ä¸»åŠ¨è„‰ç˜¤å¹³æ»‘è‚Œç»†èƒå†…æºæ€§ CSE/Hâ‚‚S çš„æ–°å‹è¡¨è§‚é—ä¼ æœºåˆ¶ [ChIP-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296864)
- [GSE287736 æ€§åˆ«ç‰¹å¼‚æ€§ KDM6A-HNF4A-CREBH ç½‘ç»œé€šè¿‡è‚ç»†èƒçš„è¡¨è§‚é—ä¼ é‡ç¼–ç¨‹æ§åˆ¶è„‚è›‹ç™½èƒ†å›ºé†‡ä»£è°¢å’ŒåŠ¨è„‰ç²¥æ ·ç¡¬åŒ–](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287736)
- [GSE287680 æ€§åˆ«ç‰¹å¼‚æ€§ KDM6A-HNF4A-CREBH ç½‘ç»œé€šè¿‡è‚ç»†èƒçš„è¡¨è§‚é—ä¼ é‡ç¼–ç¨‹æ§åˆ¶è„‚è›‹ç™½èƒ†å›ºé†‡ä»£è°¢å’ŒåŠ¨è„‰ç²¥æ ·ç¡¬åŒ– [CUT&Tag]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287680)
- [GSE261694 Agonistic GITR therapy in combination with chemotherapy to promote tumor immunity in pancreatic ductal adenocarcinoma](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE261694)
- [GSE244562 AtDEK2ï¼Œä¸€ç§åŒç»„è›‹ç™½æ ‡è®°è¯»å–è›‹ç™½ï¼Œè°ƒæ§æ¤ç‰©å…ç–«](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE244562)
- [GSE319829 CD8+ T ç»†èƒåˆ†åŒ–çŠ¶æ€ä¸‹ STAT5 æ—ç³»åŒæºåŸºå› çš„ä¸å¯¹ç§°æ€§å’Œå†—ä½™æ€§](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319829)
- [GSE319604 GPR43é€šè¿‡è°ƒèŠ‚TGF/Smadä¿¡å·é€šè·¯æŠ‘åˆ¶é«“æ ¸ç»†èƒè¡°è€](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319604)
- [GSE317586 ç ”ç©¶è¡¨æ˜ï¼Œ3-ç¾ŸåŸºç¡¬è„‚é…¸é€šè¿‡ALKBH5/PAX-8/ABCA1é€šè·¯ä¿ƒè¿›èƒ†å›ºé†‡å¤–æµå¹¶å‡è½»åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ã€‚](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317586)
- [GSE316523 è§£æERK5ä¿¡å·é€šè·¯åœ¨ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­çš„èƒŒæ™¯ç‰¹å¼‚æ€§æ•ˆåº”](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316523)
- [GSE314831 COP9ä¿¡å·ä½“æ˜¯ç»´æŒè„‚è‚ªç»„ç»‡å’Œä»£è°¢å¥åº·æ‰€å¿…éœ€çš„](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314831)
- [å¯¹è‡ªç„¶æ„ŸæŸ“å‰¯ç»“æ ¸åˆ†ææ†èŒï¼ˆMycobacterium avium subsp. paratuberculosisï¼‰çš„äºšä¸´åºŠè·æ–¯å¦ç‰›çš„è¡€æ¶²å’Œç©ºè‚ æ ·æœ¬è¿›è¡ŒGSE313938 RNA-Seqåˆ†æï¼Œæ­ç¤ºäº†å®¿ä¸»å¯¹æ½œä¼æ€§å‰¯ç»“æ ¸åˆ†ææ†èŒæ„ŸæŸ“çš„è½¬å½•é€‚åº”æ€§ã€‚](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313938)
- [GSE313646 æ¿€æ´»çš„å¹²æ‰°ç´ ä¿¡å·æŠ‘åˆ¶å¹´é¾„ä¾èµ–æ€§è‚ç™Œ [RNAseq_è‚ç»†èƒ]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313646)
- [GSE313551 Myt3ç¿»è¯‘å¤±è°ƒä½¿èƒ°å²›Î²ç»†èƒåœ¨è‚¥èƒ–è¯±å¯¼çš„ä»£è°¢åº”æ¿€ä¸‹æ˜“å‘ç”ŸåŠŸèƒ½éšœç¢](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313551)
- [GSE313201 METTL3 è¿‡è¡¨è¾¾è°ƒæ§åµå·¢ç™Œç»†èƒçš„è½¬å½•ç»„ç¨‹åº](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313201)
- [GSE313200 METTL3 æ•²ä½è°ƒæ§åµå·¢ç™Œç»†èƒçš„è½¬å½•ç»„ç¨‹åº](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313200)
- [GSE311309 æ¯”è¾ƒ 45 æ—¥é¾„ä¸»ç»†èƒç‰¹å¼‚æ€§ Tsc1 æ•²é™¤ (Tsc1f/f/Aqp2 Cre) ä¸é‡ç”Ÿå‹ (WT) å°é¼ çš„è‚¾è„è½¬å½•ç»„ã€‚](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311309)
- [GSE311308 æ¯”è¾ƒ28æ—¥é¾„ä¸»ç»†èƒç‰¹å¼‚æ€§Tsc1æ•²é™¤ï¼ˆTsc1f/f/Aqp2 Creï¼‰å°é¼ ä¸é‡ç”Ÿå‹ï¼ˆWTï¼‰å°é¼ çš„è‚¾è„è½¬å½•ç»„](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311308)
- [GSE311307 æ¯”è¾ƒ45æ—¥é¾„ä¸»ç»†èƒç‰¹å¼‚æ€§Tsc1æ•²é™¤ï¼ˆTsc1f/f/Aqp2 Creï¼‰ã€45æ—¥é¾„ä¸»ç»†èƒç‰¹å¼‚æ€§Tsc1/Foxi1åŒæ•²é™¤ï¼ˆTsc1/Foxi1 dKOï¼‰å°é¼ å’Œ45æ—¥é¾„é‡ç”Ÿå‹å°é¼ çš„è‚¾è„è½¬å½•ç»„](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311307)
- [GSE310793 PRECISEï¼šç”¨äºé¢„æµ‹ä¹³å¤´çŠ¶ç”²çŠ¶è…ºç™Œé¢„åçš„ç”²çŠ¶è…ºæ»¤æ³¡ç»†èƒè¡ç”ŸåŸºå› ç‰¹å¾](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310793)
- [GSE309965 è€å¹´å°é¼ è‚è„ä¸­è‚ç»†èƒ CD44 ä¸å…ç–«è°ƒèŠ‚å’Œçº¤ç»´åŒ–å¯åŠ¨ç›¸å…³](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309965)
- [GSE308662 æ—¥æœ¬è¡€å¸è™«æ„ŸæŸ“æ—©æœŸé˜¶æ®µ CD4+ T ç»†èƒçš„å…ç–«ååº”](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308662)
- [GSE307599 å•æ ¸ RNA æµ‹åºè§£æå‡è‚¥æ‰‹æœ¯åæ£•è‰²/ç±³è‰²è„‚è‚ªç»„ç»‡å¾®ç¯å¢ƒåŠ¨æ€](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307599)
- [GSE307569 æ–°å‹äººæºåŒ–åŠŸèƒ½ç¼ºå¤±å‹NF1å°é¼ å¹¼å¹´éª¨é«“å•æ ¸ç»†èƒç™½è¡€ç—…æ¨¡å‹](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307569)
- [GSE306402 GJB2 c.109G>A çªå˜é€šè¿‡çº¿ç²’ä½“å‡‹äº¡é€”å¾„å¯¼è‡´é—ä¼ æ€§éç»¼åˆå¾æ€§è€³è‹](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306402)
- [GSE305930 å¯¹ä¸¤ä¸ªæœˆå¤§çš„ Csf1r+/- å°é¼ è„‘ç»„ç»‡è¿›è¡Œå•ç»†èƒæ ¸ RNA æµ‹åºåˆ†æ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305930)
- [GSE304101 ATM çš„ç¼ºå¤±å¯¼è‡´ R ç¯ç›¸å…³çš„è½¬å½•å¤±è°ƒï¼Œå¹¶å‡å¼±å¯¹ DNA æŸä¼¤çš„ç›¸å…³ååº” [RNA-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304101)
- [GSE303780 Atf4 å¤–æ˜¾å­ 3 ç§»ç æ•²é™¤å°é¼ èƒšèƒå¿ƒè„å‘è‚²çš„ RNA-Seq](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303780)
- [GSE303775 Rps19bp1 cKO Xmlc2Cre E11.5 å°é¼ å¿ƒè„ RNAæµ‹åº](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303775)
- [GSE303514 ARSIç»†èƒç³»æˆ–IL-10å¯¹å·¨å™¬ç»†èƒæåŒ–çš„å½±å“](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303514)
- [GSE302526 ç²ªæ†èŒä½œä¸ºç›Šç”ŸèŒç­–ç•¥å¯¹æŠ—ä»£è°¢åŠŸèƒ½éšœç¢ç›¸å…³æ€§è„‚è‚ªæ€§è‚ç‚](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302526)
- [GSE296327 å•æ ¸è½¬å½•ç»„å­¦ç ”ç©¶å°é¼ å¤§è‚ æ†èŒè‚¾ç›‚è‚¾ç‚ä¸­çš„æ€§åˆ«å·®å¼‚](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296327)
- [GSE290014 å¾®å›¾æ¡ˆåŸ¹å…»æ¿ä¸­ iPSC è¡ç”Ÿçš„è‚ºä¸Šçš®ç»†èƒ [scATAC-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290014)
- [GSE289953 é¶å‘ CPT1A å¯è§¦å‘ cGAS/STING æ¿€æ´»ï¼Œä»è€Œè°ƒåŠ¨ä¸­æ€§ç²’ç»†èƒæ¸…é™¤è‚¿ç˜¤](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289953)
- [GSE289846 å¾®å›¾æ¡ˆåŸ¹å…»æ¿ä¸­ iPSC è¡ç”Ÿçš„è‚ºä¸Šçš®ç»†èƒ [scRNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289846)
- [GSE286885 MCF-7ç»†èƒä¸­CUL4Bå’ŒKDM5Bçš„ChIPæµ‹åº](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286885)
- [GSE286175 Larp1 çš„ç¼ºå¤±ä¼šç ´å TOP mRNA çš„çªè§¦å®šä½å¹¶æŸå®³ç©ºé—´è®°å¿†ã€‚](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286175)
- [GSE283571 ç³–å°¿ç—…è‚¾ç—…ä¸­è›‹ç™½è´¨ç¨³æ€å’Œç³–è„‚ä»£è°¢çš„æ˜¼å¤œèŠ‚å¾‹é‡ç¼–ç¨‹](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283571)
- [GSE282463 å‰ªæ¥å› å­ 3a äºšåŸº 1 é€šè¿‡æŠ‘åˆ¶ Syntaxin12 çš„ç¨‹åºæ€§ç»†èƒæ­»äº¡ä¿ƒè¿›ç»“ç›´è‚ ç™Œçš„ç”Ÿé•¿ã€‚](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282463)
- [GSE282352 æ­ç¤ºè„‘è†œç˜¤ä¸­ç¼ºæ°§é©±åŠ¨çš„åŸºå› å’Œç”²åŸºåŒ–ç‰¹å¾ï¼šè¯†åˆ«æ–°çš„ç”Ÿç‰©æ ‡å¿—ç‰©å’Œæ²»ç–—é¶ç‚¹](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282352)
- [GSE282351 è§£ç è„‘è†œç˜¤è‚¿ç˜¤å‘ç”Ÿè¿‡ç¨‹ä¸­ç¼ºæ°§è¯±å¯¼çš„DNAç”²åŸºåŒ–æ¨¡å¼](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282351)
- [GSE276929 Aurka-Bhlhe41è½´å¯é¢„é˜²ç±»ä¼¼æ—©è¡°çš„å°èƒ¶è´¨ç»†èƒåŠŸèƒ½éšœç¢å¹¶ä¿ƒè¿›é«“é˜å†ç”Ÿ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE276929)
- [GSE260530 SETÎ± å’Œ SETÎ² åœ¨æ—©æœŸç»†èƒå‘½è¿å†³å®šä¸­çš„ç‹¬ç‰¹ä½œç”¨ [RNA-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE260530)
- [GSE260525 SETÎ± å’Œ SETÎ² åœ¨æ—©æœŸç»†èƒå‘½è¿å†³å®šä¸­çš„ç‹¬ç‰¹ä½œç”¨ [ChIP-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE260525)
- [GSE252019 é•¿æ˜¥èŠ±å“ç§â€œVitae Rose Redâ€çš„è½¬å½•ç»„](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE252019)
- [GSE251771 åˆ©ç”¨å°åˆ†å­æ­ç¤ºå¾ªç¯è‚¿ç˜¤ç»†èƒçš„è„†å¼±æ€§ã€‚](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE251771)
- [GSE319944 ç»„ç»‡ç¢è£‚æœ¯è¯±å¯¼çš„ç¥ç»æ¯ç»†èƒç˜¤å°é¼ æ¨¡å‹å…ç–«ååº”](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319944)
- [GSE319935 å®šä¹‰æ‰€è°“â€œå®æ€§-ç®¡å›Šæ€§è‚å†…èƒ†ç®¡ç™Œä¸ NIPBL::NACC1 èåˆè‚ç™Œâ€ä¸­å®æ€§/å‡ä¹³å¤´çŠ¶å’Œå‡è…ºçŠ¶æ¨¡å¼çš„åˆ†å­ç‰¹å¾](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319935)
- [GSE313237 å¯¹å››ç§è½¯ç»„ç»‡è‚‰ç˜¤ç»†èƒç³»è¿›è¡Œæ‰¹é‡ RNA æµ‹åºï¼Œè¿™äº›ç»†èƒç³»åœ¨ä½“å¤–ç”¨ BO-112 æˆ–è½½ä½“å¯¹ç…§å¤„ç† 6 å°æ—¶ã€‚](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313237)
- [GSE303276 æ ¸é…¸é…¶-NTPé…¶ç³»ç»Ÿåˆ©ç”¨å…±åŒçš„åˆ†å­ç‰¹å¾æ¥æ§åˆ¶ç»†èŒçš„æŠ—å™¬èŒä½“é˜²å¾¡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303276)
- [GSE301075 å•æ ¸RNAæµ‹åºæ­ç¤ºèƒ°è…ºç¥ç»å†…åˆ†æ³Œè‚¿ç˜¤ä¸­å…ç–«æŠ‘åˆ¶æ€§é«“ç³»ä¿¡å·ä¼ å¯¼å’Œä¸åŒçš„æ¶æ€§ç»†èƒçŠ¶æ€](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301075)
- [GSE297249 æœªæŠ˜å è›‹ç™½ååº”ä¿¡å·ä¿ƒè¿›é«“ç³»ç»†èƒç”Ÿæˆå¹¶ä¸è‡´ç™Œçªå˜ååŒä½œç”¨](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297249)
- [GSE294805 æ ¸å—ä½“äºšå®¶æ— 4 A ç»„æˆå‘˜ 2 (NR4A2) å¿ƒè‚Œç»†èƒç‰¹å¼‚æ€§æ¿€æ´»å¯¹å°é¼ å¿ƒè„ä¸­ poly(A) RNA è¡¨è¾¾è°±çš„å½±å“ [RNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294805)
- [GSE294803 å¿ƒè‚Œç»†èƒç‰¹å¼‚æ€§æ¿€æ´»æ ¸å—ä½“äºšå®¶æ— 4 A ç»„æˆå‘˜ 2 (NR4A2) å¯¹å°é¼ å¿ƒè„åŸºå› è¡¨è¾¾è°ƒæ§çš„å½±å“ [ChIP-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294803)
- [GSE294712 å†…çš®è„¯æ°¨é…°ç¾ŸåŒ–é…¶ 3 å‡è½»é€‚åº”ä¸è‰¯æ€§ç‚ç—‡ä»¥ä¿ƒè¿›ç¼ºè¡€åè‚¾è„ä¿®å¤](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294712)
- [GSE291056 Hh å’Œ EGFR-Ras ä¿¡å·é€šè·¯ä¿ƒè¿›æœè‡åµæ³¡ä¸Šçš®è‚¿ç˜¤è¿›å±•çš„ä¸åŒé˜¶æ®µ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291056)
- [GSE290241 Hh å’Œ EGFR-Ras ä¿¡å·é€šè·¯ä¿ƒè¿›æœè‡åµæ³¡ä¸Šçš®è‚¿ç˜¤è¿›å±•çš„ä¸åŒé˜¶æ®µ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290241)
- [GSE256099 ç¿»è¯‘ç¼ºé™· mRNA çš„ç»†èƒè´¨è¡°å˜ä¸è½¬å½•é€‚åº”ä¹‹é—´çš„è”ç³»æœºåˆ¶ [RNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE256099)
- [GSE255831 åŸºå› ç»„å¼‚è´¨æ€§é©±åŠ¨äººç±»è‚¿ç˜¤ç»†èƒçš„æœºæ¢°é€‚åº” [RRBS]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255831)
- [GSE319948 ç”Ÿç‰©ç¼©é†› 1,1-äºŒä¹™æ°§åŸºä¹™çƒ·é€šè¿‡æ¿€æ´» AMP æ¿€æ´»è›‹ç™½æ¿€é…¶å¢å¼ºæœ‰æ°§å‘¼å¸](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319948)
- [GSE319601 å†…çš®ç»†èƒ GARP è°ƒæ§è‚ºé©»ç•™ CD8 T ç»†èƒè®°å¿†çš„å¯¿å‘½](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319601)
- [GSE313731 æ•´åˆä½“å†…å’Œå¤šå‚æ•°ä½“å¤–ç­›é€‰æ­ç¤º NFIL3 æ˜¯ T ç»†èƒåŠŸèƒ½éšœç¢çš„é©±åŠ¨å› ç´ ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313731)
- [GSE313036 ç”¨äº¤æ„Ÿç¥ç»è¡ç”Ÿçš„ç»†èƒå¤–å›Šæ³¡ (SNEV) å¤„ç†çš„ä¹³è…ºç™Œ (BCa) ç»†èƒçš„åŸºå› è¡¨è¾¾è°±ã€‚](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313036)
- [GSE307041 Runxè›‹ç™½çš„ç£·é…¸åŒ–è°ƒæ§èƒ¸è…ºç»†èƒå‘½è¿ã€‚[RNA-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307041)
- [GSE290627 å†…æºæ€§CSE/Hâ‚‚Såœ¨å¹³æ»‘è‚Œç»†èƒä¸­å¯¹è…¹ä¸»åŠ¨è„‰ç˜¤çš„æ–°å‹è¡¨è§‚é—ä¼ æœºåˆ¶](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290627)
- [GSE290136 BRAF æ”¹å˜çš„å„¿ç«¥ä½çº§åˆ«èƒ¶è´¨ç˜¤çš„ç”²åŸºåŒ–è°±åˆ†æ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290136)
- [GSE289983 è‚©èƒ›ç¡¬èœ±å”¾æ¶²è…ºçš„å•ç»†èƒåˆ†è¾¨ç‡è½¬å½•ç»„](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289983)

</div>

</details>

---

*ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-02-19 21:54*  
*ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ*